Valuation: PharmaEssentia Corporation

Market Cap 519B 16.09B 14.07B 13.01B 11.94B 22.59B 1,551B 22.99B 155B 60.94B 757B 60.43B 59.11B 2,614B P/E 2026 *
48.4x
P/E 2027 * 35.2x
Enterprise Value 493B 15.27B 13.35B 12.34B 11.33B 21.44B 1,471B 21.81B 147B 57.83B 719B 57.35B 56.09B 2,481B EV / Sales 2026 *
19.7x
EV / Sales 2027 * 14x
Free-Float
75.37%
Yield 2026 *
0.08%
Yield 2027 * 0.12%
1 day-4.55%
1 week-8.65%
Current month+4.31%
1 month+46.82%
3 months+115.03%
6 months+161.74%
Current year+197.38%
1 week 1,165
Extreme 1165
1,365
1 month 887.06
Extreme 887.0636
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - 01/08/2022
Director TitleAgeSince
Director/Board Member 78 01/03/2014
Director/Board Member 73 01/05/2024
Director/Board Member - 30/06/2006
Change 5-day change 1-year change 3-year change Capi.($)
-4.55%-8.65%+194.32%+349.58% 16.9B
-3.42%+10.05%+58.59%+87.70% 57.82B
-0.05%-5.85%+54.36%+71.44% 53.71B
-2.60%-9.72%+2.07%+415.75% 23.8B
-0.11%-1.30%-18.42%-14.40% 23.26B
-0.56%+10.26%+44.03%-3.86% 20.7B
-0.29%-2.05%+34.41%-29.62% 17.81B
-2.61%+8.99%+46.11%+691.67% 16.36B
+0.41%-2.42%+24.35%+190.36% 13.96B
-2.18%-3.96%+55.92%+141.16% 12.69B
Average -1.63%+0.68%+49.57%+189.98% 25.7B
Weighted average by Cap. -1.68%+0.04%+48.79%+153.81%

Financials

2026 *2027 *
Net sales 25.07B 777M 679M 628M 576M 1.09B 74.84B 1.11B 7.49B 2.94B 36.55B 2.92B 2.85B 126B 34.57B 1.07B 936M 866M 794M 1.5B 103B 1.53B 10.32B 4.06B 50.39B 4.02B 3.93B 174B
Net income 10.85B 336M 294M 272M 249M 472M 32.4B 480M 3.24B 1.27B 15.82B 1.26B 1.24B 54.63B 14.97B 464M 405M 375M 344M 651M 44.7B 663M 4.47B 1.76B 21.83B 1.74B 1.7B 75.35B
Net Debt -26.52B -822M -718M -664M -610M -1.15B -79.18B -1.17B -7.92B -3.11B -38.67B -3.09B -3.02B -133B -34.73B -1.08B -940M -870M -798M -1.51B -104B -1.54B -10.37B -4.07B -50.63B -4.04B -3.95B -175B
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
16/07/26 TWD 1,260.00 -4.55% 4,406,182
15/07/26 TWD 1,320.00 +10.00% 2,157,754
14/07/26 TWD 1,200.00 -4.00% 4,037,292
13/07/26 TWD 1,250.00 -2.72% 3,373,173
09/07/26 TWD 1,285.00 -6.84% 6,711,957
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,260.00TWD
Average target price
1,057.48TWD
Spread / Average Target
-16.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock